Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.75
Delayed Data
As of Sep 03
 +0.005 / +0.18%
Today’s Change
2.60
Today|||52-Week Range
9.37
-54.62%
Year-to-Date

Today’s Trading

Previous close2.75
Today’s open2.77
Day’s range2.74 - 2.88
Volume2,176,290
Average volume (3 months)2,362,022
Market cap$344.2M
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)-111.87%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1,519.63%
P/E ratioNM
Price/Sales12.91
Price/Book15.17

Competitors

 Today’s
change
Today’s
% change
LIFEaTyr Pharma Inc+0.23+1.59%
IMDZImmune Design Corp-1.15-6.80%
IDRAIdera Pharmaceutical...-0.06-2.03%
LBIOLion Biotechnologies...-0.15-2.14%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$55.5M
Annual profit (last year)-$37.5M
Net profit margin-67.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers